
Researchers have discovered that ACBP, a protein elevated in diabetic hearts, drives both metabolic imbalance and structural damage in cardiomyocytes, leading to heart dysfunction. Mouse models show that knocking out ACBP improves heart structure and function, while overexpression worsens it. Targeting ACBP may offer a new way to treat cardiac issues in type 2 diabetes patients.
Like
Save
Share